Emerging as a niche at the intersection between healthcare and technology, femtech has rapidly grown and gained momentum, becoming a powerful force set to disrupt the healthcare industry.
The sector consists of tech-powered products and services aimed at improving women’s health across a broad variety of applications. It comprises a few hundred startups developing innovative projects, as well as more established biotech, biopharma and diagnostics companies targeting specific areas of women’s healthcare.
Femtech includes a wide range of sub-segments, spanning fertility, period tracking, pregnancy and maternal care to menopause; sexual health; conditions like endometriosis, hormonal imbalances and premenstrual syndrome; and mental health, pain management and wellbeing.
The global femtech market generated $820.6m in 2019 and is expected to reach at least $3bn by the end of 2030, based on data from PitchBook. Another report recently published by Frost & Sullivan forecasts the sector’s revenue to hit $1.1bn by 2024, increasing at a compound annual growth rate (CAGR) of 12.9%, while FemTech Analytics…
